Zai Lab Announces First Patient Dosed in China in a Global Phase 3 Study of Retifanlimab in Patients with NSCLC
SHANGHAI and SAN FRANCISCO, Oct. 05, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial […]
Cytokinetics Announces Data From Two Presentations at the HFSA Virtual Annual Scientific Meeting 2020
Real-World Population Representative of Patients Enrolled in GALACTIC-HF Indicate a High-Need, High-Risk Population with Heart FailureNew Results from COSMIC-HF Show Treatment […]
Intellia Therapeutics Names John F. Crowley to Board of Directors
CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
Primoris Services Corporation Announces Industrial Award Valued Over $110 Million
DALLAS, Oct. 05, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the […]
TSX News -
AirBoss Announces US$22.0 Million in Awards Across ADG’s Survivability Portfolio
NEWMARKET, Ontario, Oct. 05, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced […]
Leaf Group Announces Preliminary Third Quarter 2020 Results
Records Highest Quarterly Revenue Growth Rate Since the Company’s 2011 IPO, Highest Quarterly Revenue Since FY2013Society6 Group Posts Record Quarterly […]
FTI Consulting Professionals Named to Crain’s Notable Women in Accounting and Consulting List
WASHINGTON, Oct. 05, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that four professionals have been named […]
Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
Angel’s pipeline will feature Corvus’ three clinical-stage candidates – ciforadenant, CPI-006 and CPI-818 – and its preclinical BTK inhibitor programStrategic […]
New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19
Enrollment in first three cohorts complete; final cohort now enrolling with plans to initiate a pivotal study before year-endData continues […]
Liquidia Names Gerald M. O’Brien, MD, as Vice President, Pulmonary Clinical Development
RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company […]
